https://timesofindia.indiatimes.com/life-style/health-fitness/health-news/breakthrough-medication-significantly-cuts-risk-of-heart-attacks-and-strokes-lancet-study/articleshow/118285409.cms
A newly approved drug for type 2 diabetes and kidney disease, sotagliflozin, has shown remarkable benefits in reducing the risk of heart attacks and s
Create an account or login to join the discussion